FiberOptix Ultra 8 IAB: 8Fr 40cc
Medical device recall Z-1057-2016. Published in FDA’s Enforcement Report on Mar 16, 2016.
- FDA Class I
No Watch here, and no alerts: openFDA asks that its enforcement data “should not be used as a method to collect data to issue alerts to the public, nor should it be used to track the lifecycle of a recall” (openFDA). For FDA’s own recall emails, subscribe at FDA. FDA’s own record is on accessdata.fda.gov.
The short answer
Published in FDA’s Enforcement Report on Mar 16, 2016. Copied from openFDA on Oct 20, 2026.
- Class I FDA’s most serious class (needs attention)
- Terminated its status, in FDA’s file
- Nationwide FDA’s word for where it went
- 13,405 US and 33,735 OUS in total how much, in FDA’s words
Every line below is in FDA’s own words, with its source beside it. FDA’s terms are explained in FDA’s own words.
How serious is it, by FDA’s class?
Class I, the most serious of FDA’s three classes.
“Dangerous or defective products that predictably could cause serious health problems or death. Examples include: food found to contain botulinum toxin, food with undeclared allergens, a label mix-up on a lifesaving drug, or a defective artificial heart valve.”
openFDA, in plain words, its enforcement report fields.
“Class I is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.”
FDA’s rule, 21 CFR 7.3(m)(1), eCFR.
What these words mean is quoted from openFDA’s field reference and 21 CFR 7.3.
What’s wrong with it?
The sheath body may become separated from the sheath hub. If the separation occurs, there is a potential for bleeding from the device.
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
Which ones are recalled?
FiberOptix Ultra 8 IAB: 8Fr 40cc; Product Code: IAB-05840-LWS The Arrow¿ IAB is utilized for intra aortic balloon counterpulsation therapy in the aorta, whereby balloon inflation, during diastole and deflation, during systole increases blood supply to the heart muscle and decreases work of the left ventricle.
13,405 US and 33,735 OUS in total, in FDA’s words.
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
Codes to check against yours
Batch: 18F14A0025 18F14A0026 18F14A0030 18F14A0049 18F14A0050 18F14A0051 18F14A0054 18F14A0057 18F14A0066 18F14A0067 18F14D0045 18F14E0004 18F14E0006 18F14E0016 18F14E0017 18F14E0052 18F14F0017 18F14F0047 18F14F0049 18F14F0080 18F14G0003…
Every code shown here, 1,062 characters
Batch: 18F14A0025 18F14A0026 18F14A0030 18F14A0049 18F14A0050 18F14A0051 18F14A0054 18F14A0057 18F14A0066 18F14A0067 18F14D0045 18F14E0004 18F14E0006 18F14E0016 18F14E0017 18F14E0052 18F14F0017 18F14F0047 18F14F0049 18F14F0080 18F14G0003 18F14G0004 18F14G0021 18F14G0037 18F14G0055 18F14G0056 18F14G0068 18F14G0070 18F14G0071 18F14G0076 18F14H0009 18F14H0030 18F14H0054 18F14H0055 18F14H0060 18F14H0061 18F14J0003 18F14J0005 18F14J0037 18F14K0006 18F14M0001 18F14M0014 18F14M0032 18F15A0005 18F15A0011 18F15A0026 18F15A0034 18F15B0005 18F15B0008 18F15B0010 18F15B0018 18F15B0020 18F15B0027 18F15C0002 18F15C0007 18F15C0010 18F15C0015 18F15C0024 18F15C0030 18F15C0036 18F15D0017 18F15D0032 18F15D0034 18F15D0043 18F15D0049 18F15E0003 18F15E0011 18F15E0014 18F15E0023 18F15E0029 18F15E0037 18F15F0011 18F15F0017 18F15F0021 18F15F0032 18F15G0001 18F15G0013 18F15G0021 18F15G0028 18F15G0034 18F15H0010 18F15H0015 18F15H0021 18F15H0024 18F15H0033 18F15J0013 18F15J0028 18F15J0038 18F15J0044 18F15J0049 18F15K0001 18F15K0007 18F15L0002 18S14G0068 18S14M0001 18S15C0002
Copied exactly as FDA lists them: lot and serial numbers, dates and other codes on the product or its label.
Where did it go?
FDA’s words for the “general area of initial distribution”: where the firm first shipped it.
Worldwide Distribution: US (Nationwide) and countries of: Argentina, Australia, Belgium, Brunei Darussalam, Brazil, Bahamas, Canada, Chile, China, Colombia, Ecuador, Guatemala, Hong Kong, Indonesia, India, Japan, Korea (Republic of [South] Korea), Myanmar, Mexico, Malaysia, Nepal, New Zealand, Panama, Peru, Philippines, Pakistan, Singapore, Thailand, Trinidad and Tobago, Taiwan, Uruguay, Viet Nam, and South Africa (Zuid Afrika).
These words name no state.
What FDA means by nationwide
“The term “nationwide” is defined to mean the fifty states or a significant portion. Note that subsequent distribution by the consignees to other parties may not be included.”
openFDA, its enforcement report fields.
The words say it went outside the United States too.
What these words mean is quoted from openFDA’s field reference and 21 CFR 7.3.
Is it still going on?
Terminated, in FDA’s file.
“FDA has determined that all reasonable efforts have been made to remove or correct the violative product in accordance with the recall strategy, and proper disposition has been made according to the degree of hazard.”
openFDA, on “Terminated”, its enforcement report fields.
What these words mean is quoted from openFDA’s field reference and 21 CFR 7.3.
- The firm began the recall on Feb 10, 2016.
- FDA classified it on Mar 10, 2016.
- FDA’s Enforcement Report published it on Mar 16, 2016.
- FDA terminated it on May 12, 2021.
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
Who is recalling it?
- Arrow International, Inc., Division of Teleflex Medical Inc., of Everett, MA.
- Who began it, in FDA’s words: Voluntary: Firm initiated.
- How the firm first told its customers: Letter.
FDA, Device recall enforcement reports. Released Oct 14, 2026. Updated weekly.
What this record can’t tell you
- Whether your own one is affected: compare the codes, dates and numbers above with yours. When unsure, ask the firm or the store.
- Where it went after the firm’s first shipments. FDA’s words cover the firm’s initial distribution, and, in FDA’s words, “subsequent distribution by the consignees to other parties may not be included.”
- How many have been returned, corrected or destroyed: FDA’s report doesn’t say.
- Whether anyone was hurt or fell ill: the report doesn’t say.
- How current it is: openFDA publishes FDA’s Enforcement Report weekly, after FDA does, and a firm can announce a recall weeks before it appears there. openFDA’s own caution: “This data should not be used as a method to collect data to issue alerts to the public, nor should it be used to track the lifecycle of a recall.”
- A product with no recall here isn’t safe by that: FDA’s report lists the recalls FDA classified, and when.
Hearth Record wrote these lines; the quotations are FDA’s.
Sources
-
U.S. Food and Drug Administration, Device recall enforcement reports.
Released Oct 14, 2026 and checked Oct 20, 2026. Updated weekly. Public domain (CC0 1.0, openFDA). FDA asks that nothing suggest it endorses this site.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.” Copied on Oct 20, 2026.